Literature DB >> 11403738

Overlap of fibromyalgia with other medical conditions.

M Martínez-Lavín1.   

Abstract

Fibromyalgia is a multisystem illness. One of its defining features, generalized pain, may also be present in other rheumatic entities. The diagnosis of fibromyalgia is not easy by any means, it requires a profound knowledge of internal medicine. This article discusses the different rheumatic and nonrheumatic diseases that overlap or are prone to be confused with fibromyalgia. It emphasizes the key points in the differential diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11403738     DOI: 10.1007/s11916-001-0024-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  15 in total

1.  Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients.

Authors:  T H Milhorat; M W Chou; E M Trinidad; R W Kula; M Mandell; C Wolpert; M C Speer
Journal:  Neurosurgery       Date:  1999-05       Impact factor: 4.654

2.  Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.

Authors:  I J Russell; M D Orr; B Littman; G A Vipraio; D Alboukrek; J E Michalek; Y Lopez; F MacKillip
Journal:  Arthritis Rheum       Date:  1994-11

Review 3.  Is fibromyalgia a generalized reflex sympathetic dystrophy?

Authors:  M Martínez-Lavín
Journal:  Clin Exp Rheumatol       Date:  2001 Jan-Feb       Impact factor: 4.473

Review 4.  Current issues in the diagnosis and treatment of Sjögren's syndrome.

Authors:  R I Fox; J Tornwall; P Michelson
Journal:  Curr Opin Rheumatol       Date:  1999-09       Impact factor: 5.006

5.  Fibromyalgia-associated hepatitis C virus infection.

Authors:  J Rivera; A de Diego; M Trinchet; A García Monforte
Journal:  Br J Rheumatol       Date:  1997-09

6.  The overdiagnosis of fibromyalgia syndrome.

Authors:  M A Fitzcharles; J M Esdaile
Journal:  Am J Med       Date:  1997-07       Impact factor: 4.965

Review 7.  Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review.

Authors:  A J Reginato; G F Falasca; R Pappu; B McKnight; A Agha
Journal:  Semin Arthritis Rheum       Date:  1999-04       Impact factor: 5.532

8.  A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.

Authors:  K De Meirleir; C Bisbal; I Campine; P De Becker; T Salehzada; E Demettre; B Lebleu
Journal:  Am J Med       Date:  2000-02       Impact factor: 4.965

9.  Prevalence of primary and secondary fibrositis.

Authors:  F Wolfe; M A Cathey
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

10.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02
View more
  5 in total

Review 1.  Fibromyalgia, fatigue, and headache disorders.

Authors:  Mario F P Peres
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Experiences of patients with fibromyalgia at a Finnish Health Centre: A qualitative study.

Authors:  Aleksi Varinen; Tiina Vuorio; Elise Kosunen; Tuomas H Koskela
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

Review 3.  GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?

Authors:  G Cuatrecasas; C Alegre; F F Casanueva
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

4.  Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.

Authors:  Ina Kötter; Daniela Neuscheler; Ilhan Günaydin; Dorothee Wernet; Reinhild Klein
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

5.  Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgia.

Authors:  Maria I Bokarewa; Malin C Erlandsson; Jan Bjersing; Mats Dehlin; Kaisa Mannerkorpi
Journal:  Mediators Inflamm       Date:  2014-08-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.